Related Experiment Video

Updated: Mar 16, 2026

Author Spotlight: Addressing Regulatory Gaps in Molecular Studies by Quantifying Viral Vectors in Complex Matrices
07:43

Author Spotlight: Addressing Regulatory Gaps in Molecular Studies by Quantifying Viral Vectors in Complex Matrices

Published on: July 14, 2023

3.0K

Rethinking the Regulatory Infrastructure for Human Gene Transfer Clinical Trials

Christopher L Jenkins1, Mark L Bagarazzi2, Hans-Peter Kiem3

  • 1WCG Biosafety, WIRB-Copernicus Group, Princeton, New Jersey, USA.

Molecular Therapy : the Journal of the American Society of Gene Therapy
|August 11, 2016
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

A GMP-Compliant Procedure for the Generation of Gene-Modified T cells
06:47

A GMP-Compliant Procedure for the Generation of Gene-Modified T cells

Published on: October 6, 2023

1.1K
Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
06:18

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

3.9K

Related Experiment Videos

Last Updated: Mar 16, 2026

Author Spotlight: Addressing Regulatory Gaps in Molecular Studies by Quantifying Viral Vectors in Complex Matrices
07:43

Author Spotlight: Addressing Regulatory Gaps in Molecular Studies by Quantifying Viral Vectors in Complex Matrices

Published on: July 14, 2023

3.0K
A GMP-Compliant Procedure for the Generation of Gene-Modified T cells
06:47

A GMP-Compliant Procedure for the Generation of Gene-Modified T cells

Published on: October 6, 2023

1.1K
Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
06:18

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

3.9K

Related Concept Videos

Gene Therapy00:59

Gene Therapy

27.9K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.9K
What is Genetic Engineering?00:49

What is Genetic Engineering?

81.1K
Overview
81.1K

Articles linked to this work by shared authors, journal, and citation graph.

Associative memory plays a role in ER-1α positive breast cancers.

Cell death and differentiation·2026

Distinct genomic and immunologic tumor evolution in germline TP53-driven breast cancers.

Nature communications·2026

The TP53 gene contains a diversity box that makes it more than a tumor suppressor.

Cell death and differentiation·2026

Neoantigenic properties of TP53 variants influence cancer risk in individuals with Li-Fraumeni syndrome.

EBioMedicine·2025

The roles of mutant p53 in reprogramming and inflammation in breast cancers.

Cell death and differentiation·2025

Restoring p53 wild-type conformation in TP53-Y220C-mutant acute myeloid leukemia.

Blood·2025

Advanced iPSC-based modelling of LMNA-related congenital muscular dystrophy enables development of genetic therapies for muscle laminopathies.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Intranasal delivery of a vasoactive intestinal peptide-based circRNA vaccine induces systemic and mucosal immunity against RSV in mice.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Antisense oligonucleotides against Il6ra ameliorate cancer cachexia in mice.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Leveraging host cell modulators of adeno-associated vectors transduction to tailor viral biodistribution.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Pan-Cancer Oncolytic Virotherapy Through Disruption of Tumor Cell Mitochondrial Dynamics.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

A complement C5-targeted GalNAc-conjugated siRNA with sustained efficacy in a non-human primate model of IgA nephropathy.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Polycation chain length determines the in vivo mRNA delivery efficiency of block copolymer micelles.

Biomaterials science·2026

Driving Drugs Deeper: Force-Driven Microneedle Systems for Active Therapy and Their Road Towards Clinical Implementation.

Small (Weinheim an der Bergstrasse, Germany)·2026

Mumio Potentiates Temozolomide by Inducing Apoptosis and Ferroptosis in Glioblastoma Cells.

Current pharmaceutical design·2026

Current Targeted Nanoparticle Therapy for Alzheimer's Disease: Current Advances and Future Prospects.

Current neurovascular research·2026

Clinical Presentation, Diagnosis, Treatment, and Outcome of Heart Disease in Becker Muscular Dystrophy.

Anatolian journal of cardiology·2026

Clinical Pharmacology of Eplontersen, the First Approved GalNAc-Conjugated Antisense Oligonucleotide.

Journal of clinical pharmacology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us